Rare diseases
Investigational molecules
Locations
Back to Italy58 clinical trials in Cremona, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on Reduced Dose of Alteplase for Patients with Intermediate-High-Risk Acute Pulmonary Embolism
ItalyStudy on Trastuzumab and Pertuzumab for Patients with HER2-Positive Breast Cancer Using a Response-Adapted Strategy
ItalyStudy of Enfortumab Vedotin and Pembrolizumab for Patients with Advanced or Metastatic Urothelial Cancer
ItalyStudy of Romiplostim Treatment for Chemotherapy-induced Low Blood Platelets in Adults with Gastrointestinal, Pancreatic, or Colorectal Cancer Receiving Oxaliplatin Chemotherapy
ItalyStudy of Sacituzumab Govitecan for Patients with Advanced or Metastatic Bladder Cancer
ItalyStudy on Giredestrant and Fulvestrant with CDK4/6 Inhibitor for Patients with ER+ HER2-Negative Advanced Breast Cancer Resistant to Endocrine Therapy
ItalyStudy of Pembrolizumab in Patients with Esophageal Cancer Undergoing Chemoradiotherapy
ItalyStudy on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack
ItalyStudy Comparing Tivozanib and Nivolumab Combination to Tivozanib Alone in Patients with Renal Cell Carcinoma After Previous Immune Therapy
ItalyStudy on Talazoparib and Enzalutamide for Patients with Metastatic Castration-Resistant Prostate Cancer
ItalyThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on non-small cell lung cancer are evaluating novel therapeutic approaches, including combination treatments with targeted therapies and immunotherapy agents.
Studies are investigating treatments for patients with specific genetic mutations and exploring alternatives to traditional chemotherapy.
Research in gastric and pancreatic cancers is exploring innovative combination therapies and maintenance treatments to improve patient outcomes.
Studies are evaluating both targeted therapies and immunotherapy approaches for these challenging cancers.
Trials in prostate cancer and bladder cancer are investigating new treatment strategies, including hormone therapy combinations and immunotherapy approaches.
Research focuses on improving survival outcomes and quality of life for patients with advanced disease.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
